A Phase 1 Study of Topotecan Liposomes Injection (TLI) in Subjects With Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Topotecan (Primary)
- Indications Ovarian cancer; Small cell lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Spectrum Pharmaceuticals; Talon Therapeutics
- 16 Oct 2017 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018.
- 16 Oct 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2018.
- 16 Jun 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov.